Federal contract award
HT942525F0237
ANTIBODY & ANTIGEN SUPPLY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | HT942525D0009 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $110.5K |
| Current contract value | $110.5K |
| Potential contract value / ceiling | $110.5K |
| Start date | Jun 6, 2025 |
| Current end date | Dec 4, 2025 |
| Potential end date | Dec 4, 2025 |
| Latest award activity | Jan 22, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 22, 2026 | P00003 | $0 | MONOCLONAL ANTIBODIES AND VIRAL RECOMBINANT ANTIGENS |
| Dec 23, 2025 | P00002 | $0 | MONOCLONAL ANTIBODIES AND VIRAL RECOMBINANT ANTIGENS |
| Jul 9, 2025 | P00001 | $0 | ANTIBODY AND ANTIGEN SUPPLY |
| Jun 5, 2025 | 0 | $110.5K | ANTIBODY & ANTIGEN SUPPLY |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.